Month: May 2021

WISeKey International Holding Ltd Schedules a Conference Call to Discuss the Agenda Items of its 2021 Annual General Meeting of Shareholders Zug, Switzerland, May 6, 2021 – WISeKey International Holding Ltd. (“WISeKey” or “Company”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity and IoT company, announced today that will hold a conference call on Wednesday, May 12, 2021 at 3:00 pm CET (9:00 am ET) to discuss the agenda items of the proposal our Board of Directors has recommended for shareholder approval at the 2021 Annual General Meeting of Shareholders (“AGM“), scheduled for May 25, 2021. A question and answer session will follow management’s prepared remarks. WISeKey’s shareholders can participate in the event by registering at www.wisekey.com/agm2021. As previously announced, due to the extraordinary situation in connection...

Broadening of the addressable market for Maxigesic IV in Latin America and the Caribbean to 17 countriesMaxigesic IV has potential to combat the opioid epidemic in pain management Liège, Belgium – 6 May 2021 – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to bringing innovative treatments that offer added value to underserved patient populations, today announces that its partner for Maxigesic IV, AFT Pharmaceuticals (“AFT”), has extended its existing license and distribution agreement with Pharma Bavaria International for the commercialisation of Maxigesic IV, a novel, patented, non-opioid treatment for post-operative pain, in South America. The extended collaboration further builds on the agreement signed with Pharma Bavaria in February 2020 for the commercialisation of Maxigesic IV in...

  –Yselty® for uterine fibroids: US New Drug Application submission planned in Q3:21; European marketing approval recommendation anticipated in Q4:21– –Yselty® for endometriosis: Readout from Phase 3 EDELWEISS 3 study expected in Q4:21– –Ebopiprant: Phase 2b dose ranging study planned to initiate in Q4:21 based on positive Phase 2a proof of concept– –Actively pursuing new indications and partnerships to maximize value of pipeline candidates–                  GENEVA, Switzerland and BOSTON, MA – May 6, 2021 – ObsEva SA (NASDAQ: OBSV) (SIX: OBSN) (ObsEva or the Company), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today reported financial results for the quarter ended March 31, 2021 and provided a business update. “The outset...

COMMENTARY FROM MANAGEMENT In Q1 2021, Merko Ehitus posted revenue of EUR 60 million and net profit of EUR 3.4 million, increasing by 7% and 67%, respectively, compared to the previous year. In three months, Merko sold 90 apartments and started construction of more than 560 apartments. The volume of the new construction contracts and secured order book also increased in the first quarter. The management of Merko Ehitus is satisfied with the financial results of the first quarter. Despite the lack of new commercial real estate projects, the construction market in the Baltic Republics is currently quite active. At the same time, prospects remain unclear due to the continuing pandemic and the global rise in material prices. In the first quarter, Merko sold 90 apartments in Tallinn, Tartu, Riga and Vilnius. The apartment market is relatively...

Sanofi establishes three-year collaboration with Stanford Medicine to accelerate immunology researchProjects led by collaborating researchers from the two organizations will focus on autoimmune diseases and inflammatory conditionsPARIS and Palo Alto, CA – May 6, 2021 – Sanofi has entered into a three-year research collaboration with Stanford University School of Medicine. Together, the two organizations and their scientists will work to advance the understanding of immunology and inflammation through open scientific exchange. Additionally, Sanofi will provide funding and scientific inputs into projects of mutual interest, crossing multiple therapeutic areas including autoimmune diseases and inflammatory conditions. “We look forward to working with some of the most innovative scientists in the human immunology community. Together...

First quarter revenue shows solid return to growth at +14.3%1versus 2020Revenue above 2019 level1 despite COVID-19 pandemic, up 2% at constant exchange rates1 Strong momentum in prescription lenses and optical retail E-commerce up 61% versus 2019 at constant exchange rates1 North America, China and Australia driving the performance Strong balance sheet and free cash flow5 generationCharenton-le-Pont, France (May 6, 2021 – 7:00am) – EssilorLuxottica today announced that consolidated revenue for the first quarter of 2021 totalled Euro 4,060 million, representing a year-on-year increase of 7.3% compared to the first quarter of 2020 (+14.3% at constant exchange rates1). Consolidated revenue grew by 1.9% at constant exchange rates1 compared to the first quarter of 2019. “EssilorLuxottica had a strong start to the year. While the pandemic...

Oslo, 6 May 2021 – DNO ASA, the Norwegian oil and gas operator, today reported operating profit of USD 66 million in the first quarter of 2021, following four quarters of losses triggered by market perturbations from the global Covid pandemic. The turnaround was driven by solid production, cost optimization, higher oil prices and regularization of payments from Kurdistan. The Company stepped up spend early in the year with drilling of new wells and workovers of existing ones in its flagship Tawke license to sustain gross operated production from the Tawke and Peshkabir fields at 112,000 barrels of oil per day (bopd) in the first quarter, up from 110,000 bopd in the previous quarter. Net production attributable to the Company’s interest across the portfolio, including from DNO’s North Sea oil and gas assets, stood just shy of 100,000 barrels...

Saint-Herblain (France), May 6, 2021 – Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announced today the pricing of its initial public offering on the Nasdaq Global Select Market by way of a capital increase of 7,082,762 new ordinary shares, consisting of a public offering of 2,318,881 American Depositary Shares (“ADSs”), each representing two ordinary shares  (the “U.S. Offering”), and a concurrent private placement of 2,445,000 ordinary shares in Europe (including in France) and other countries outside of the United States (the “European Private Placement”, and, together with the U.S. Offering, the “Global Offering”). The aggregate gross proceeds are expected to be approximately $93.5 million, equivalent...

Hexagon Ragasco, a Hexagon Composites company, received its first order in 2021 from a long-term customer in South Asia. The total estimated value of the order is USD 3.8 million (approx. NOK 32 million). Driving energy transformation The use of LPG for cooking produces practically no particulates. Its CO2 footprint is 20% lower than that of heating oil and 50% lower than coal. Use of Hexagon Ragasco’s easy-to-handle lightweight, LPG composite cylinders provide a safer and cleaner fuel alternative, while also enabling people to spend less time cooking and gathering fuel, and more time on education and income generation. “This region of the world is facing the tough effects of the pandemic. Continuing our work with key customers in this region to support their local efforts to meet basic domestic cooking needs safely and efficiently is...

Luxembourg, May 6, 2021 – ArcelorMittal (referred to as “ArcelorMittal” or the “Company”) (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world’s leading integrated steel and mining company, today announced results1 for the three-months ended March 31, 2021. 1Q 2021 Key highlights:Health and safety performance: Protecting the health and wellbeing of employees remains the Company’s overarching priority; LTIF rate of 0.78x in 1Q 20212 Significantly improved operating performance in 1Q 2021, reflecting the continued demand recovery which supported a 6.5% sequential increase in steel shipments (to 16.5Mt vs. scope adjusted3 15.5Mt in 4Q 2020), the continued positive evolution of steel spreads, and the benefits of iron ore vertical integration 1Q 2021 operating income of $2.6bn vs. $2.0bn4 in 4Q 2020. EBITDA of $3.2bn...